ERBB2 and breast carcinoma: Some diseases have been distinguished using blood-based biomarkers, such as human epidermal growth factor receptor 2 (HER2) for breast cancer (26, 27) and epidermal growth factor receptor (EGFR) for lung cancer (28, 29).